Answers are grounded in this paper and cite their sources.
Randomized trial shows improved pain relief in knee osteoarthritis with combined celecoxib and Jintiange capsules, suggesting beneficial integration of therapies.
Background:Knee osteoarthritis (KOA) poses a substantial global health burden, and conventional nonsteroidal anti-inflammatory drug (NSAID) therapy with celecoxib is hindered by adverse effects.This study evaluated the efficacy and safety of combining celecoxib with Jintiange capsules, a synthetic tiger bone formulation used in traditional Chinese medicine (TCM), to manage symptomatic KOA.Material/Methods: This 12-week, randomized, double-blind, placebo-controlled trial enrolled 120 patients with KOA (age 40 years; visual analog scale [VAS] score 4-7).Participants received celecoxib (200 mg/day tapered to 100 mg/day) combined with either Jintiange capsules (3.6 g/day) or placebo.The primary outcome was the change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score.Secondary outcomes included WOMAC subscale scores (pain, function, and stiffness), VAS scores, and adverse drug reaction reports. Results:The experimental group demonstrated a 23.5-point (37.8%) reduction in WOMAC total score from baseline (P<0.001); the control group showed a 13.2-point (21.6%) reduction (P<0.001).The experimental group achieved 51.6% improvement in the WOMAC pain subscale (P<0.001),whereas the control group showed 33.3% improvement (P<0.001).Relative to the control group, the experimental group demonstrated a greater reduction in VAS score (P<0.001).Combined TCM-NSAID therapy produced significantly greater pain relief and functional improvement than NSAID monotherapy. Conclusions:Celecoxib combined with Jintiange capsules provided clinically meaningful improvements in pain relief and functional outcomes relative to celecoxib monotherapy in patients with KOA.These findings support integration of TCM with conventional pharmacotherapy for osteoarthritis management.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: